Cystic Fibrosis Therapy
Research data from Mpex Pharmaceuticals update understanding of cystic fibrosis therapy
Published in Anti-Infectives Week, March 1st, 2010
Current study results from the report, 'Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients,' have been published. According to a study from the United States, "Studies have demonstrated that thickened mucous layers in the lungs of cystic fibrosis (CF) patients contain areas of low oxygen tension. These microaerophilic environments may reduce the activity of aerosol antibiotics used in the management of chronic infection in CF."
"The aim of this study was to compare the MICs of levofloxacin, tobramycin, amikacin, and aztreonam against...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2010-03-01)
More Articles from Anti-Infectives Week
- Angiotensins
Studies in the area of angiotensins reported from Sankyo Co., Ltd. - Antimicrobials
New antimicrobials study findings recently were published by researchers at University of New South Wales - Atopic Dermatitis
Data on atopic dermatitis described by researchers at University of Minnesota - Daptomycin Therapy
Study results from O. Burkhardt and colleagues broaden understanding of daptomycin therapy - Drug Resistance
New drug resistance study findings have been reported by M.A. Argudin and co-researchers - Drug Resistance
Scientists at University of British Columbia target drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
